Navigation Links
Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
Date:3/10/2011

bmitted marketing applications for fidaxomicin in the EU and the U.S., and presented additional data showing that CDI patients treated with fidaxomicin experienced 47% fewer recurrences than patients treated with vancomycin," said Pedro Lichtinger, Optimer's President and CEO.  "With the progress we made in 2010, we believe fidaxomicin, if approved, is positioned to become a first line treatment for CDI for patients at risk of recurrence.  We expect 2011 to be a year of commercial execution marked by the potential launch of fidaxomicin."

"The rapid progress we've made so far in 2011 is a testament to the strength of the fidaxomicin program," added Lichtinger.  "In 2011 we have signed a partnership agreement with Astellas to commercialize fidaxomicin in Europe and certain other countries in the Middle East, Africa and CIS, added key commercialization capabilities to our management team and published Phase 3 data in The New England Journal of Medicine."

The Company expects to provide 2011 financial guidance after obtaining further clarity on the outcome of the Advisory Committee Meeting and achieving an FDA registration.

Optimer 2010 and Recent Highlights

  • Announced collaboration with Astellas Pharma Europe Ltd. to develop and commercialize fidaxomicin for the treatment of Clostridium difficile infection (CDI), in Europe and certain other countries in the Middle East, Africa, and the Commonwealth of Independent States.  Optimer received a $69.2 million upfront cash payment and is eligible to receive milestone payments of up to approximately 115.0 million Euros and tiered double-digit royalty payments on net sales of fidaxomicin in the territory.
  • Raised $73.1 million in net proceeds in a public offering of common stock in February 2011.  Also raised $51.2 million in net proceeds in a public offering of common stock in March 2010.
  • Fidaxomicin North American Phase 3 trial results w
    '/>"/>

  • SOURCE Optimer Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
    2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
    3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
    4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
    5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
    6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
    7. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
    8. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
    9. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
    10. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
    11. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/1/2015)... REDWOOD CITY, Calif. , May 1, 2015  AcelRx ... company focused on the development and commercialization of innovative ... today announced that Timothy E. Morris , chief ... events.  Details of the events are as follows: ... Tuesday, May 5 Location:  The Omni Berkshire Place, ...
    (Date:4/30/2015)... ON , April 30, 2015 /PRNewswire/ - ... specialty pharmaceutical company with a focus on Omega-3 ... announced its operational highlights and financial results for ... dollar amounts referenced herein are in Canadian dollars ... 2014 have been significant, with the right strategic ...
    (Date:4/30/2015)... SUNNYVALE, Calif. , April 30, 2015 /PRNewswire/ ... that it has signed an agreement with MIM ... for the TomoTherapy ® and CyberKnife ® ... both Accuray and MIM technology. This is Accuray,s ... to the development of the first iPad-based treatment ...
    Breaking Medicine Technology:AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May 2Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 3
    ... , , ... SILVER SPRING, Md. , Jan. 18 The ... a counterfeit and potentially harmful version of Alli 60 mg ... ) , Preliminary laboratory tests conducted by GlaxoSmithKline (GSK) -- ...
    ... , Kidney Care Partners, Members Provide Dialysis Equipment, ... Access to Life-Saving Treatment , PORT-AU-PRINCE, Haiti ... an earthquake that has devastated this Caribbean country, ... of millions of dollars as well as dialysis equipment, medications, ...
    Cached Medicine Technology:FDA Warns Consumers about Counterfeit Alli 2FDA Warns Consumers about Counterfeit Alli 3U.S. Kidney Dialysis Community Responds to Haiti's Emergency Plea for Life-Saving Dialysis Care 2U.S. Kidney Dialysis Community Responds to Haiti's Emergency Plea for Life-Saving Dialysis Care 3
    (Date:5/2/2015)... As one of only 30 Illinois ... and Health Achievement and Recognition Program (SHARP) certification, ... by the Illinois Department of Labor to host this ... SHARP certification by the Occupational Safety and Health Administration’s ... continued to meet or exceed all of the necessary ...
    (Date:5/2/2015)... Vancouver fencing company, QS Fencing, has recently announced that its ... related to their questions on railings and gates. Many people ... and patios. While that seems like an easy task, there ... rolls up their sleeve to start working. One of the ... gate that matches it. , Instead of spending hours worrying ...
    (Date:5/2/2015)... ProText Kinetic 2 is a set of typography ... X. ProText Kinetic 2 features 40 animation presets ... X . Easily create interactive text videos without having ... Kinetic 2. , Using ProText Kinetic is as easy as ... presets in the FCPX timeline. Playback the default animation ...
    (Date:5/2/2015)... 2015 We are pleased to announce ... Center as one of the Top Workplaces of 2015. ... addiction treatment field for their ethics and standards of ... to continue their educational efforts. The Delray Recovery Center ... forgetting their purpose – to help individuals heal from ...
    (Date:5/2/2015)... On Tuesday April 7th, the patient ... to celebrate improvements in patient care. In 2014 the ... had zero acquired ventilator associated infections, zero central line ... was also recently named a Top Performer by the ... credited the teamwork of staff from all departments involved ...
    Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2
    ... going blind and not know it. Silently, without symptoms, Glaucoma ... ,January is Glaucoma Awareness Month, and the American Academy ... urges everyone to get a complete eye exam, especially if ... ,* African-Americans older than 40 ,* Hispanics ,* People with ...
    ... long been associated with an increased risk of injury ... says a recent study// by a University of Missouri, Columbia. ... Vinson, professor of community and family medicine, found that patients ... injured. However, patients who reported better sleep quality in the ...
    ... New research published in the Jan. 10 issue of ... University chemists// and North Carolina State University toxicologists, finds ... ,This research was based on the ... buckyball-containing amino acids. "Our results confirm that repetitive ...
    ... new software-based approach to detect osteoporosis while doing routine ... width of a part of the patient`s lower jaw. ... at the University’s School of Dentistry adapted the ‘active ... of Imaging Sciences and use it to automatically detect ...
    ... younger someone starts drinking alcoholic beverages, the more likely ... to relieve stress when older, a large new study ... among persons who started drinking at 14 or younger ... drinking are already higher than those of other drinkers,” ...
    ... undergone a hip replacement surgery and is resting comfortably//. ... the Mayo Clinic in Rochester, Minnesota said on its ... of the current president. His surgery came two days ... of former president Gerald Ford, who died Dec 26 ...
    Cached Medicine News:Health News:Glaucoma: Silently Stealing Sight from Millions 2Health News:A Study Explores the Medical Potentials of Bucky Amino Acids 2Health News:Youngest Drinkers Likelier to Use Alcohol for Stress Relief as Adults 2
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: